SAN FRANCISCO, June 12, 2018 /PRNewswire/ --
The global biological safety testing market size is expectedto reach USD 5.54 billion by 2024, according to a new report by Grand View Research, Inc., registering a CAGR of 12.2% during the forecast period. The market is predominantly driven by increasing influx of biologics, which
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
Increasing prevalence of lifestyle-associated chronic diseases such as cancer and diabetes serves as a key contributing factor toward increasing drug development and their subsequent commercialization. This is presumed to raise the need to scrutinize and ensure safety of targeted and specialized therapies, evaluate their outcomes, and circumvent probable shortcomings. As a consequence of high manufacturing intensity, pharmaceutical and biotechnology companies are increasingly incorporating biological safety testing tools to produce highly potent and contamination-free biologics to cater to the large population suffering from target diseases.
Viral safety testing is proving to be one of the primary concerns of most companies as it is a critical component of chemistry, manufacturing, and control of biologics. This presents the market with several potential growth opportunities in future.
Laboratory-based contaminations have stimulated the development and refinement of workstations by incorporating biological safety tools. Need to work with tissue cultures, maintain sterility of cell lines, and minimize cross-contamination has contributed to concerns regarding product integrity. The aforementioned factors are responsible for raising concerns of public organizations. Consistent intervention by government healthcare organizations to implement good manufacturing practices and subsequent testing and control at every production stage is believed to widen the growth opportunities of the market.
Browse full research report with TOC on "Biological Safety Testing Market Size, Share & Trends Analysis Report By Product, By Application (Vaccines & Therapeutics, Gene Therapy, Stem Cell), By Test, By Region, And Segment Forecasts, 2018 - 2024" at: https://www.grandviewresearch.com/industry-analysis/biological-safety-testing-market
Further Key Findings From the Report Suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global biological safety testing market on the basis of product, application, test, and region:
Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All